Stay updated with breaking news from Sam Rua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WATERTOWN, Mass., March 28, 2023 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors... | March 28, 2023
WATERTOWN, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc., a clinical-stage oncology therapeutics company with proprietary...
NDA Partners President Earle Martin announced today that Sam Rua, a regulatory affairs and quality assurance management executive with more than 24 years of experience in vitro diagnostics product development, has joined the firm as an Expert Consultant. Throughout his career, Mr. Rua has successfully established and maintained effective quality and regulatory programs, provided leadership across all areas of the medical diagnostics business, and serves as an active member of the IVD regulatory